welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Thetis Pharmaceuticals Awarded Key Patent on HEALER Technology
Thetis Pharmaceuticals LLC, a privately-held biopharmaceutical company focused on gastrointestinal and cardiometabolic diseases, announced today that the USPTO has granted patent US 9,242,008 providing composition of matter protection for two Thetis development candidates, TP-252 for familial adenomatous polyposis and TP-452 for dyslipidemia. The allowed claims include pharmaceutical compositions that are mineral amino-acid based derivatives of fatty acids. National filings outside of the United States are underway.
expertly curated content related to this topic
-
Vanderbilt University Medical CenterSpeciality Clinic Patient Resources: ...
-
Laparoscopic Total Colectomy and Proctocolectomy for the Treatment of Familial Adenomatous PolyposisOBJECTIVE : To evaluate the safety, feas...
-
Samir Gupta, MDSamir Gupta, MD, is a board-certified Ga...
-
Body Image, Cosmesis, Quality of Life, and Functional Outcome of Hand-Assisted Laparoscopic Versus Open Restorative ...BACKGROUND : This study aimed to compare...
-
Sonia Kupfer, MDSonia Kupfer, MD, is an expert in digest...
-
Bonnies Diary Jan 08https://jtvcancersupport.com/embed/29153...
-
Genetic Counseling 101With many rare diseases there is often a...